Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis
Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis
Recruiting · NCT06375005 · Registry updated 2025-02-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis | Skin and Connective Tissue Diseases, connective tissue disorder, diffuse scleroderma, skin disorder, systemic sclerosis | Recruiting | Phase 2 | 2025-02-11 | NCT06375005 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 561 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Affiliated Hospital of Yangzhou University | Yangzhou | China | 1 |
| Changxing People's Hospital | Huzhou | China | 1 |
| Hangzhou First People's Hospital | Hangzhou | China | 15 |
| Huashan Hospital of Fudan University | Shanghai | China | 1 |
| Ningbo First Hospital | Ningbo | China | 3 |
| Sir Run Run Shaw Hospital, Zhejiang University School of Medicine | Hangzhou | China | 24 |
| The First Affiliated Hospital of Wenzhou Medical University | Wenzhou | China | 87 |
| The First Hospital of Jiaxing | Jiaxing | China | 6 |
| The Second Affiliated Hospital of Zhejiang University School of Medicine | Hangzhou | China | 2 |